Jiao Xia

Jiao Xia

Auto-generated profile, based on publicly available information

Jiao Xia

Department of Otorhinolaryngology Head and Neck Surgery Beijing Friendship Hospital of Capital Medical University Beijing China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Chemosphere
Verified
Journal Article
Closed access
JJJiaxin Jia
Jiaxin Jia
JXJiao Xia
Jiao Xia
RZRuxiang Zhang
Ruxiang Zhang
YBYi Bai
Yi Bai
SLShen Liu
Shen Liu
TCTian Chen
Tian Chen

13 February 2015 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
JXJiao Xia
Jiao Xia
WWWei Wang
Wei Wang
DZDaoxing Zhang
Daoxing Zhang
The facial recess approach is preferred in common cavity (CC) malformation with an incomplete basal turn, and the transmastoid single-slit labyrinthotomy approach in classic CC malformation. Patients with CC benefit from cochlear implantation (CI) over time, but the audiological and speech development is poorer than in cases with normal cochleas. To discuss the surgical aspects and performance of CI in 21 patients with CC malformation. Twenty-one CC malformations were classified into 2 types: classic CC malformation and CC malformation with an incomplete basal turn. Twenty-one patients without inner ear malformation were set as the control group. Thus, data for 42 patients were analyzed. The facial recess approach was used in 3 patients with CC malformation with an incomplete basal turn, and the transmastoid single-slit labyrinthotomy approach in 18 patients with classic CC malformation. After follow-up for 36 months, the average free-field hearing threshold was higher, and the scores for the CAP, SIR, IT-MAIS, and closed-set/open-set auditory speech perception tests were lower than in the control group (p < 0.05).

19 January 2025 in Allergy
Verified
Journal Article
Open access
SASemah Abdu
Semah Abdu
JXJiao Xia
Jiao Xia
HYHuihui Yuan
Huihui Yuan
TTTiak Ju Tan
Tiak Ju Tan
JLJanice A. Layhadi
Janice A. Layhadi
STStephen J. Till
Stephen J. Till
Background: Alarmin cytokine IL‐25 promotes type 2 inflammatory responses in disorders such as asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) and known targets include ILC2 and Th2 cells. However, other cellular targets for IL‐25 remain poorly defined. Objective: To investigate induction and expression of IL‐25 receptor (IL‐17RB) by B cells and evaluate responsiveness of IL‐17RB‐expressing B cells to IL‐25 in vitro. Methods: IL‐17RB expression, regulation and function on B cells were evaluated in peripheral blood‐derived B cells by flow cytometry and RT‐PCR, including in response to IgE‐inducing stimuli (anti‐CD40 mAb and IL‐4). Single‐cell RNA sequencing was used to compare IL‐17RB+ and IL‐17RB‐activated peripheral blood‐derived B cells. To evaluate B cell IL‐17RB expression within type 2 inflamed tissue, B cells were compared from nasal polyps, control turbinate tissue and matched peripheral blood. Results: Activation of B cells with anti‐CD40 and IL‐4 increased IL‐17RB expression at both protein and mRNA level, which was further upregulated by IL‐25. B cells induced to express IL‐17RB responded to IL‐25 with enhanced antibody production. Single‐cell RNA‐sequencing showed that IL17RB+ activated B cells expressed higher levels of IGHE, CCL17 and CCL22 compared to IL17RB‐ B cells. B cells from nasal polyp tissue expressed higher levels of surface IL‐17RB compared with control tissue, correlating with patient‐reported CRSwNP severity (SNOT‐22). Conclusion: Peripheral blood B cells activated under IgE‐inducing conditions express surface IL‐17RB, and tissue IL‐17RB+ B cells are increased in type 2 inflammation. IL‐17RB+ cells have a distinct transcriptional profile and respond to IL‐25 with enhanced antibody production, highlighting the IL‐25/IL‐17RB pathway as a potential therapeutic target for CRSwNP and other type 2 inflammatory disorders.

20 May 2019 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
JXJiao Xia
Jiao Xia
YMYouxiang Ma
Youxiang Ma
HTHao Tian
Hao Tian
RZRuxiang Zhang
Ruxiang Zhang
Background: Many techniques have been proposed to close an oroantral fistula (OAF), with most of them involving transoral repairs with oral soft tissue flaps. An additional Caldwell-Luc approach or endoscopic sinus surgery (ESS) is required to address coexisting maxillary sinusitis. Objectives: This study presents the endonasal closure of an OAF through modified endoscopic medial maxillectomy (MEMM) with a free nasal mucoperichondrial-osteal graft. Materials and methods: Sixteen OAF patients who underwent closure operations in our department from May 2013 to June 2018 were retrospectively reviewed. Results: The main cause of OAF was maxillary dental cysts (56.25%). The OAF size ranged from 2 × 2 to 10 × 15 mm. The first molar (62.5%) was the most frequently involved tooth. All closures were made via MEMM, using nasal mucoperichondrial-osteal grafts harvested from the septum or nasal base. All patients were followed up for at least six months. Successful closure after a single procedure was achieved in 93.75% of cases. No obvious complications or recurrences were observed. Conclusions: Endonasal repair of OAFs via MEMM with free nasal mucosal grafts is feasible and promising. The approach preserves the normal oral and nasal physiology after surgery. It could be used alone for the closure of small to medium-sized OAFs.

17 March 2026 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
XWXueting Wang
Xueting Wang
JCJunge Chen
Junge Chen
JXJiao Xia
Jiao Xia
TMTeng Ma
Teng Ma
WYWeitong Yang
Weitong Yang
TCTian Chen
Tian Chen

12 July 2026 in Interdisciplinary Medicine
Verified
Journal Article
Open access
PDF file
XWXueting Wang
Xueting Wang
JCJunge Chen
Junge Chen
JXJiao Xia
Jiao Xia
WYWeitong Yang
Weitong Yang
TMTeng Ma
Teng Ma
TCTian Chen
Tian Chen
Parkinson's disease (PD) is characterized by the progressive loss of dopaminergic neurons. However, conventional therapies primarily manage symptoms rather than promote neural restoration. Mesenchymal stem cell‐derived small extracellular vesicles (sEVs) represent promising therapeutic strategies, but their clinical utility is limited by poor brain‐targeting efficiency and low loading capacity. To address these limitations, we developed a nanomedicine platform (BDNF@RVG‐sEVs) using a membrane fusion strategy. We fused high‐potency human nasal mucosa mesenchymal stem cell derived sEVs, harvested from a 3D dynamic culture system, with RVG‐modified liposomes pre‐loaded with brain‐derived neurotrophic factor. This platform leverages the bioactivity of 3D‐cultured sEVs while bypassing the macromolecular loading constraints inherent to traditional sEVs. Our results demonstrate that, compared to native sEVs, intranasal administration of BDNF@RVG‐sEVs significantly enhances brain accumulation and cargo stability. This targeted delivery led to improved behavioral performance, maintained dopaminergic neuron integrity, and promoted endogenous neurogenesis in mice with manganese‐induced PD‐like damage. Mechanistically, transcriptomic and metabolomic analyses revealed that these therapeutic effects may be related to the activation of neurotrophic pathways and the restoration of systemic metabolic homeostasis. Overall, this nanomedicine provides a potential strategy for the targeted treatment of neurodegenerative conditions.